- 专利标题: Substituted piperidine compound and use thereof
-
申请号: US15421702申请日: 2017-02-01
-
公开(公告)号: US10287305B2公开(公告)日: 2019-05-14
- 发明人: Tatsuhiko Fujimoto , Kentaro Rikimaru , Hiromichi Sugimoto , Takahiro Matsumoto
- 申请人: Takeda Pharmaceutical Company Limited
- 申请人地址: JP Osaka
- 专利权人: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人地址: JP Osaka
- 代理机构: Foley & Lardner LLP
- 优先权: JP2016-019834 20160204
- 主分类号: C07D211/56
- IPC分类号: C07D211/56 ; C07F7/18 ; C07D211/24 ; C07D401/14 ; C07D405/06 ; C07D413/06 ; C07D409/06 ; C07D401/06 ; C07D409/12 ; C07D401/12 ; C07D405/12 ; C07D417/06 ; C07D417/14 ; C07D405/14
摘要:
Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy.
公开/授权文献
- US20170226137A1 SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF 公开/授权日:2017-08-10